Evolent Health Inc. (EVH)
8.96
-0.27 (-2.93%)
At close: Apr 17, 2025, 3:59 PM
9.01
0.57%
After-hours: Apr 17, 2025, 08:00 PM EDT
-2.93% (1D)
| Bid | 8.93 |
| Market Cap | 1.04B |
| Revenue (ttm) | 2.55B |
| Net Income (ttm) | -61.62M |
| EPS (ttm) | -0.82 |
| PE Ratio (ttm) | -10.93 |
| Forward PE | 15.45 |
| Analyst | Buy |
| Ask | 9.07 |
| Volume | 2,642,530 |
| Avg. Volume (20D) | 2,748,026.2 |
| Open | 9.16 |
| Previous Close | 9.23 |
| Day's Range | 8.63 - 9.21 |
| 52-Week Range | 8.35 - 33.63 |
| Beta | 1.20 |
About EVH
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and adminis...
Sector Healthcare
IPO Date Jun 5, 2015
Employees 4,500
Stock Exchange NYSE
Ticker Symbol EVH
Website https://www.evolenthealth.com
Analyst Forecast
According to 14 analyst ratings, the average rating for EVH stock is "Buy." The 12-month stock price forecast is $15, which is an increase of 67.41% from the latest price.
Stock ForecastsNext Earnings Release
Evolent Health Inc. is scheduled to release its earnings on May 8, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-9.77%
Evolent Health shares are trading lower after RBC ...
Unlock content with
Pro Subscription
5 months ago
+13.25%
Evolent Health shares are trading higher. Barclays maintained an Overweight rating on the stock.
